Latest filing published 06 Feb 2014 for Eiger BioPharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Enterprise Partners Management LLC: trading record in brief
This profile gathers the share dealings of Enterprise Partners Management LLC across 2 companies, led by Eiger BioPharmaceuticals, Inc. and Complete Genomics Inc. Over a trading history stretching from 16 November 2010 to 4 February 2014, the count stands at 7 filings.
On the market, this insider has only ever bought: 2 purchases, €1.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2014 alone, the filings show 1 purchase and no sales.
The latest filing, published on 6 February 2014, reports a transaction in Eiger BioPharmaceuticals, Inc. The last insider purchase was made public on 6 February 2014, 4,659 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Enterprise Partners Management LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 926,621 sharesCommon StockSEC:0001209191-14-007966:0
- 459,668 sharesCommon StockSEC:0001209191-14-007966:1
- 13,553 shares@ US$8.00Common StockSEC:0001209191-14-007966:2
- 133,083 shares@ US$8.00Common StockSEC:0001209191-14-007966:3Canonical exit: 5 May 2014 (T+90)
- 66,138 sharesCommon Stock, par value $0.001SEC:0001181431-10-055865:0
- 27,049 sharesCommon Stock, par value $0.001SEC:0001181431-10-055865:1
6 of 6 declarations
